 |
 |
"As we noted last month, monkey trials using BLSI's DAT blocker candidate in a Parkinson's model showed mixed evidence for functional benefit, and a very worrisome emergence of orafacial dyskinesia. If that were to crop up in non-Parkinsonian patients, that would be the death knell for the ADHD program, and may well be the end for it in Parkinson's. " http://www.neuroinvestment.com/BLSIcom.html definitely the death knell in non parkinsonian patients maybe the death knell in parkinsonian patients __________________________________________________ Do You Yahoo!? Tired of spam? Yahoo! Mail has the best spam protection around http://mail.yahoo.com ---------------------------------------------------------------------- To sign-off Parkinsn send a message to: mailto:[log in to unmask] In the body of the message put: signoff parkinsn